» Articles » PMID: 28962346

Safety Assessment of Superba™ Krill Powder: Subchronic Toxicity Study in Rats

Overview
Journal Toxicol Rep
Date 2017 Oct 1
PMID 28962346
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The safety of krill powder was assessed in a subchronic 13-week toxicity study where rats were fed krill powder or control diets. The krill powder inclusion in the test diet was 9.67% (w/w). There were no differences noted in body weight or food consumption in either gender. Differences in clinical chemistry values were noted in the krill powder-treated animals, but these findings were of no toxicological significance. A significant decrease in absolute heart weight, but not relative heart weight, was observed in both sexes given krill powder, although no corresponding histological changes were observed. Hepatocyte vacuolation was noted histologically in males fed krill powder. This finding was not associated with other indications of hepatic dysfunction. The no observed adverse effect level (NOAEL) for the conditions of this study was considered to be 9.67% krill powder.

Citing Articles

A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis.

Hill W, Dohnalek M, Ha Y, Kim S, Jung J, Kang S Nutrients. 2023; 15(17).

PMID: 37686801 PMC: 10490060. DOI: 10.3390/nu15173769.


A 90-day dietary study with fibrillated cellulose in Sprague-Dawley rats.

Ong K, Ede J, Pomeroy-Carter C, Sayes C, Mulenos M, Shatkin J Toxicol Rep. 2020; 7:174-182.

PMID: 32021807 PMC: 6994281. DOI: 10.1016/j.toxrep.2020.01.003.


A toxicity profile of the Pheroid® technology in rodents.

Kleynhans J, Elgar D, Ebenhan T, Zeevaart J, Kotze A, Grobler A Toxicol Rep. 2019; 6:940-950.

PMID: 31673495 PMC: 6816226. DOI: 10.1016/j.toxrep.2019.08.012.


Krill products: an overview of animal studies.

Burri L, Johnsen L Nutrients. 2015; 7(5):3300-21.

PMID: 25961320 PMC: 4446753. DOI: 10.3390/nu7053300.

References
1.
Robertson B, Burri L, Berge K . Genotoxicity test and subchronic toxicity study with Superba™ krill oil in rats. Toxicol Rep. 2017; 1:764-776. PMC: 5598210. DOI: 10.1016/j.toxrep.2014.07.007. View

2.
Batetta B, Griinari M, Carta G, Murru E, Ligresti A, Cordeddu L . Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J Nutr. 2009; 139(8):1495-501. DOI: 10.3945/jn.109.104844. View

3.
Berge K, Piscitelli F, Hoem N, Silvestri C, Meyer I, Banni S . Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men. Lipids Health Dis. 2013; 12:78. PMC: 3680309. DOI: 10.1186/1476-511X-12-78. View

4.
Bjorndal B, Vik R, Brattelid T, Vigerust N, Burri L, Bohov P . Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. Metabolism. 2012; 61(10):1461-72. DOI: 10.1016/j.metabol.2012.03.012. View

5.
Takaichi S, Matsui K, Nakamura M, Muramatsu M, Hanada S . Fatty acids of astaxanthin esters in krill determined by mild mass spectrometry. Comp Biochem Physiol B Biochem Mol Biol. 2003; 136(2):317-22. DOI: 10.1016/s1096-4959(03)00209-4. View